在马查多 - 约瑟夫病的息治疗方法
Mara Arruda1, Carolina Vidal2, Maria João Serpa2
1Unidade de Saúde da Ilha Terceira - Centro de Saúde da Praia da Vitória, Portugal.
Journal of palliative medicine
|February 27, 2025
概括
这项研究描述了第一个马查多-约瑟夫病 (MJD) 患者队列在息治疗中,识别了诸如吞困难和失眠等常见症状. 多学科方法显著改善了晚期MJD患者的生活质量.
科学领域:
- 神经学 神经学
- 抚慰性护理是一种缓解性护理.
背景情况:
- 脊髓小脑缩症 (SCAs) 是一种罕见的神经退行性疾病.
- 马查多-约瑟夫病 (MJD) 是最常见的自体主导性无氧.
- 对于MJD,目前还没有改变疾病的治疗方法;建议提供息治疗.
研究的目的:
- 描述由息治疗团队管理的MJD患者的第一个队列.
- 为了确定先进的MJD中普遍存在的症状.
- 详细介绍改善生活质量的多学科干预措施.
主要方法:
- 在息治疗单元 (PCU) 中对MJD患者的回顾性分析.
- 收集的数据包括人口统计,功能状态,症状得分,治疗方法和高级护理计划.
- 使用非参数统计测试进行分析.
主要成果:
- 随访时间中位数为5年;疾病持续时间中位数为18.5年.
- 最常见的症状是吞困难,便秘,抑郁症和失眠 (在MJD中更为普遍).
- 死亡率为30%,其中55%的死亡与疾病进展有关.
结论:
- 这是PCU中MJD患者的第一个队列描述.
- 吞困难,便秘,抑郁和失眠是MJD晚期的关键症状.
- 跨学科的方法,与药物治疗一起,对于管理先进的MJD至关重要.
相关概念视频
Continuing Care
1.4K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.4K
Parkinson's Disease: Treatment
182
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
182
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Peptic Ulcer Disease IV: Management
58
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
58
Chronic Pancreatitis II: Collaborative Care
56
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
56
Inflammatory Bowel Disease IV: Pharmacological Management
88
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
88

